The future of pharmacology

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Vallance, Patrick ^a   Smart, Trevor G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical pharmacology; Perspective; Pharmacology

Indexed keywords

ACETYLCHOLINE; ANTICONVULSIVE AGENT; DRUG RECEPTOR; GLUCOCORTICOID; GLYCOPROTEIN P; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKING AGENT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ANTIBODY;

CONCENTRATION RESPONSE; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SYNTHESIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HUMAN; KNOCKOUT MOUSE; POLICY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION; TREATMENT FAILURE; VASODILATATION;

DRUG INDUSTRY; DRUG THERAPY; FORECASTING; PHARMACOGENETICS; PHARMACOLOGY; TEACHING;

EID: 30444441613     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706454     Document Type: Review

References (13)

1. ABPI. (2005). Facts & Statistics from the pharmaceutical industry. http://www.abpi.org.uk/statistics.
2. BIOSCIENCE INNOVATION & GROWTH TEAM. (2003). Published by DTI.
3. CASAS, J.P., BAUTISTA, L.E., SMEETH, L., SHARMA, P. & HINGORANI, A.D. (2005). Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet, 365, 194-196.
4. CHASMAN, D.I., POSADA, D., SUBRAHMANYAN, L., COOK, N.R., STANTON JR, V.P. & RIDKER, P.M. (2004). Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA, 291, 2821-2827.
5. DEAN, B., SCHACHTER, M., VINCENT, C. & BARBER, N. (2002). Causes of prescribing errors in hospital inpatients: a prospective study. Lancet, 359, 1371-1378.
6. FELDMANN, M. & MAINI, R.N. (2003). Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med., 9, 1245-1250.
7. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
8. GALEN ON PHARMACOLOGY. (1995). Philosophy, history and medicine. In: Proceedings of the Fifth International Galen colloquium. ed. Debru, A. Amsterdam: Brill Academic Publishers.
9. HOUSE OF COMMONS REPORT ON PHARMACEUTICAL INDUSTRY. (1995). House of Commons Health Select Committee. Published by the Stationery Office Ltd.
10. LAUDER BRUNTON, T. (1880). Medicine Past and Present. London: MacMillan.
11. PIRMOHAMED, M., JAMES, S., MEAKIN, S., GREEN, C., SCOTT, A.K., WALLEY, T.J., FARRAR, K., PARK, B.K. & BRECKENRIDGE, A.M. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ, 329, 15-19.
12. SCHEINDLIN, S. (2001). A brief history of pharmacology. Modern Drug Discovery, 4, 87-88.
13. SIDDIQUI, A., KERB, R., WEALE, M.E., BRINKMANN, U., SMITH, A., GOLDSTEIN, D.B., WOOD, N.W. & SISODIYA, S.M. (2003). Association of multidrug reistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med., 348, 1480-1482.